共 50 条
- [13] Enteral Access is not Required for Esophageal Cancer Patients Undergoing Neoadjuvant Therapy ANNALS OF THORACIC SURGERY, 2016, 102 (03): : 948 - 954
- [16] The Pretreatment Systemic Inflammatory Response is an Important Determinant of Poor Pathologic Response for Patients Undergoing Neoadjuvant Therapy for Rectal Cancer Annals of Surgical Oncology, 2017, 24 : 1295 - 1303
- [19] IMMUNE CORRELATES OF PATHOLOGIC RESPONSE IN BLADDER CANCER PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY JOURNAL OF UROLOGY, 2017, 197 (04): : E1178 - E1178